Using exome sequencing of 24 patients with confirmed ACC, Frierson et al. identified chromatin remodelling mutations in 50% of ACC patients, including ARID1A, CREBBP, EP300 and KDM6A. Here, EP300 is linked to adrenal cortex carcinoma.